Trial intelligence / Profile preview

Discontinuation of ethambutol in pulmonary tuberculosis based on MTBDRplus assay

KCT0000610Phase 4Completed

Sponsor
Korean National Tuberculosis Association
Start
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ethambutol in pulmonary tuberculosis (TB), sponsored by Korean National Tuberculosis Association. Started Nov 2012; status: completed.

02

Drugs

ethambutol
03

Conditions

pulmonary tuberculosis (TB)

Beyond the preview

Go deeper on KCT0000610.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0000610.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call